Xeris Pharmaceuticals Inc (XERS) — Long-term Investment Intensity
Xeris Pharmaceuticals Inc (XERS) has a Long-term Investment Intensity of 1.1% as of June 2020. Long-term investments of $1.79 Million represent 1.1% of total assets of $165.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See XERS net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Xeris Pharmaceuticals Inc Long-term Investment Intensity (2019–2019)
This chart shows how Xeris Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2019 to 2019. As of June 2020, the intensity stands at 1.1%, reflecting long-term investments of $1.79 Million against total assets of $165.81 Million USD. Also explore Xeris Pharmaceuticals Inc balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Xeris Pharmaceuticals Inc (2019–2019)
The table below presents the year-by-year Long-term Investment Intensity for Xeris Pharmaceuticals Inc from 2019 to 2019, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Xeris Pharmaceuticals Inc worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 12.1% | $13.23 Million | $108.99 Million | — |